Trial intelligence / Profile preview

Survey of SARS-CoV-2 antibody retention and health status before and after COVID-19 vaccination in school staff

jRCT1061200057Completed

Sponsor
Kawasaki Medical School
Start
Feb 2021
Countries
1
01

Overview

Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Kawasaki Medical School. Primary endpoint: Transition of SARS-CoV-2 serum antibody titer. Started Feb 2021; status: completed.

02

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on jRCT1061200057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1061200057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call